<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03828032</url>
  </required_header>
  <id_info>
    <org_study_id>Brain edema dehydration</org_study_id>
    <nct_id>NCT03828032</nct_id>
  </id_info>
  <brief_title>Multi-parameters'Change Process During Dehydration Therapy on Brain Edema Patients.</brief_title>
  <official_title>Alternations of Multi-parameters Including Hemodynamic Concentration and Water Levels During Dehydration Therapy on Brain Edema Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ting Li</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Affiliated Hospital of Armed Police Logistics College</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Chinese Academy of Medical Sciences</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to investigate the inner mechanism during different dehydration therapies
      such as mannitol injection and hypertonic saline. The investigators used a self-made near
      infrared spectroscopy (NIRS) instrument to monitor the physiological changes noninvasively
      including oxyhemoglobin ([HbO2]), deoxy-hemoglobin ([Hb]), the derived change in blood volume
      ([tHb]) and water concentration on the forehead of brain edema patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Cerebral edema, as an acute head injury along with high intracranial pressure, has been of
      great interest over decades in clinical neurosurgery research. Dehydration therapy is a
      common clinical method to decrease intracranial pressure. This study aims to investigate the
      inner mechanism during different dehydration therapies such as mannitol injection and
      hypertonic saline. The investigators used a self-made near infrared spectroscopy (NIRS)
      instrument to monitor the physiological changes noninvasively including oxyhemoglobin
      ([HbO2]), deoxy-hemoglobin ([Hb]), the derived change in blood volume ([tHb]) and water
      concentration on the forehead of brain edema patients. Then the investigators compared the
      changes process of multiple physiological parameters during different dehydration therapies.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">September 1, 2019</start_date>
  <completion_date type="Anticipated">December 11, 2019</completion_date>
  <primary_completion_date type="Anticipated">November 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Δ[HbO2]</measure>
    <time_frame>2 weeks</time_frame>
    <description>changes of oxyhemoglobin concentration</description>
  </primary_outcome>
  <primary_outcome>
    <measure>water concentration</measure>
    <time_frame>2 weeks</time_frame>
    <description>water concentration of brain</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>intracranial pressure</measure>
    <time_frame>2 weeks</time_frame>
    <description>intracranial pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Δ[Hb]</measure>
    <time_frame>2 weeks</time_frame>
    <description>changes of deoxy-hemoglobin concentration</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">80</enrollment>
  <condition>Hemodynamic Instability</condition>
  <condition>Water on the Brain</condition>
  <condition>Intracranial Pressure Increase</condition>
  <arm_group>
    <arm_group_label>Mannitol injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participant receive mannitol injection to decrease intracranial pressure in the ward with optical probes on his/her forehead.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hypertonic saline injection</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The participant receive hypertonic saline of specific concentration injection to decrease intracranial pressure in the ward with optical probes on his/her forehead.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Mannitol injection</intervention_name>
    <description>Standard mannitol injection to decrease intracranial pressure of patients</description>
    <arm_group_label>Mannitol injection</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Hypertonic saline injection</intervention_name>
    <description>Standard Hypertonic saline injection to decrease intracranial pressure of patients</description>
    <arm_group_label>Hypertonic saline injection</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        • Patients who had brain edema and need dehydration therapy to decrease intracranial
        pressure.

        Exclusion Criteria:

          -  AIDS, Active Hepatitis, Tuberculosis, Syphilis

          -  Patients who regularly take anticoagulants, antiplatelet drugs

          -  Anemia, thrombocytopenia

          -  Hemorrhagic disease like hemophilia
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>July 2019</verification_date>
  <study_first_submitted>January 31, 2019</study_first_submitted>
  <study_first_submitted_qc>January 31, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 4, 2019</study_first_posted>
  <last_update_submitted>July 22, 2019</last_update_submitted>
  <last_update_submitted_qc>July 22, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">July 24, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Chinese Academy of Medical Sciences</investigator_affiliation>
    <investigator_full_name>Ting Li</investigator_full_name>
    <investigator_title>Fellow</investigator_title>
  </responsible_party>
  <keyword>Brain edema</keyword>
  <keyword>dehydration</keyword>
  <keyword>Noninvasive optical method</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Brain Edema</mesh_term>
    <mesh_term>Intracranial Hypertension</mesh_term>
    <mesh_term>Dehydration</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Mannitol</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

